On December 19, the China Medical Equipment Association hosted the "2020 Nuclear Medicine Molecular Imaging Technology Exchange" at the Novotel Peace Hotel in Beijing. The conference highlighted the latest industry developments and provided a professional platform for nuclear medicine practitioners to exchange ideas.
At the conference, Novel Medical presented the advantages and research applications of their animal PET/SPECT/CT products. This presentation garnered significant attention and recognition from numerous nuclear medicine leaders, experts, and practitioners.
Novel Medical's integrated animal PET/SPECT/CT system boasts several advanced technologies, including dual-layer crystal DOI detection, digital SiPM arrays, specialized ASIC (integrated chips), multi-pinhole confocal collimators, and high-resolution CBCT. These technologies seamlessly integrate molecular and anatomical imaging for animals, providing reliable quantitative data for preclinical medical research. It serves as a vital platform for medical studies and drug development.
Novel Medical will continue to uphold Tsinghua University's excellence in professional technology and dedicated scientific research spirit. They aim to provide comprehensive solutions for high-end nuclear technology products, increase demonstration and application efforts, promote industrialization, and support China's leapfrog development in nuclear security and nuclear medicine.
Language
